Marked atherosclerosis in a patient with familiar lecithin : cholesterol acyltransferase deficiency associated with end-stage renal disease and diabetes mellitus
S. Homma et al., Marked atherosclerosis in a patient with familiar lecithin : cholesterol acyltransferase deficiency associated with end-stage renal disease and diabetes mellitus, AM J NEPHR, 21(5), 2001, pp. 415-419
Familial lecithin:cholesterol acyltransferase (LCAT) deficiency is a rare g
enetic disorder of the lipid metabolism caused by the absence of LCAT activ
ity in plasma. It is not generally accompanied by atherosclerosis in spite
of low high-density lipoprotein cholesterol levels nor by diabetes mellitus
. However, reports of long-term followup or autopsy findings are rare, and
the true incidence of atherosclerosis in LCAT deficiency is not clear. We r
eport on the long-term observation of a patient with familial LCAT deficien
cy who developed renal failure, diabetes mellitus, and marked atheroscleros
is. The patient died of sepsis from foot ulcers 7 years after starting hemo
dialysis and 13 years after the diagnosis. Marked atherosclerosis character
ized by medial calcification in small arteries was observed at autopsy. The
genesis of the atherosclerosis seemed to be on the basis of a combination
of factors. Copyright (C) 2001 S. Karger AG, Basel.